Metabolomics: Technologies and Applications – A Global Market Overview

Published Date: Nov 2014

Report Code: BT004

Pages:508

Charts:306

Large pharma companies have yet to take on a full-blown adoption of metabolomic technologies, when compared to proteomic and genomic research. This is because of the lingering uncertainties as to the advantages offered by metabolomics that have been the outcome of failed proteomics and genomics research programs. Through some recent accomplishments have been able to dispel some of these doubts, wider adoption and acceptance of metabolomics would necessitate additional landmark successes in R&D. In all probability, the future of metabolomics is slated to hinge on discovering biomarkers for determining the presence of disease in an individual biological system. As biological inputs, such as blood glucose levels for diabetes or high cholesterol levels for heart disease, are already being utilized for confirming disease presence, metabolomics can derive benefit from an understanding of biochemical pathways. The existing focus of metabolomics has been on 20-100 different metabolites and while this constitutes a very small proportion compared to other fields of 'omics', this discipline has been making robust progress in discovering biomarkers.

Metabolomics analytical techniques analyzed in this report includes Separation Techniques - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC); and Detection Techniques - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis. The report also analyzes the metabolomics applications comprising Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications. Metabolomics therapeutic areas explored in this study includes Cardiology, Neurology, Oncology and Other Diseases.

The global markets for the above mentioned metabolomic analytical techniques, end-use applications and the therapeutic areas are analyzed in terms of value in USD. Metabolomic separation techniques account for over half of the global metabolomics market estimated at US$395.2 million in 2014 while detection techniques shares with US$308.8 million. Biomarker discovery projected to be the fastest growing end use sector with 2014-2020 CAGR of 25.2% and also estimated the largest market for metabolomics in 2014 with US$252.8 million closely followed by drug discovery with US$211.1 million.

The report reviews, analyses and projects the metabolomics technologies, applications and therapeutic areas market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 9 independent countries across North America - The United States and Canada; Europe - France, Germany, Italy and the United Kingdom; Asia-Pacific - China, India and Japan.

This 508 page global market report includes 306 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 20 key global players and 33 major players across North America - 20; Europe - 9; and Asia-Pacific - 4. The research also provides the listing of the companies engaged in research and development, manufacturing and supply of metabolomics technologies and instruments. The global list of companies covers addresses, contact numbers and the website addresses of 92 companies.

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 The Growth Drivers
1.2 Product Outline
1.2.1 What is Metabolomics?
1.2.1.1 A Brief History of Metabolomics
1.2.1.2 An Overview of Metabolomics
1.2.1.3 Concept of Metabolome
1.2.1.4 Concept of Metabolites
1.2.1.5 Concept of Metabonomics
1.2.2 Analytical Techniques in Metabolomics
1.2.2.1 A Background
1.2.2.2 Collection of Data
1.2.2.3 Separation Techniques
1.2.2.3.1 Capillary Electrophoresis (CE)
1.2.2.3.2 Gas Chromatography (GC)
1.2.2.3.3 High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
1.2.2.3.3.1 Components of HPLC
1.2.2.3.3.1.1 Injection of the Sample
1.2.2.3.3.1.2 Retention Time
1.2.2.3.3.1.3 The Detector
1.2.2.4 Detection Techniques
1.2.2.4.1 Mass Spectrometry (MS)
1.2.2.4.2 Nuclear Magnetic Resonance (NMR) Spectroscopy
1.2.2.4.3 Surface-Based Mass Analysis
1.2.2.4.4 Statistical Methods

2. APPLICATION ANALYSIS OF METABOLOMICS
2.1 Biomarker Discovery
2.2 Drug Discovery
2.2.1 Prospects of Diagnosis and Biomarkers
2.2.2 Identification and Validation of Drug Targets
2.2.3 ADMET Screening
2.2.4 Clinical Study Applications
2.3 Nutrigenomics
2.4 Toxicology Testing
2.4.1 Pathways of Toxicity (PoT)
2.5 Other Applications
2.5.1 Environmental Metabolomics
2.5.2 Functional Genomics
2.5.3 Identifying Biomarkers of Dietary Intake
2.6 Therapeutic Areas of Metabolomics
2.6.1 Cardiology
2.6.2 Neurology
2.6.3 Oncology
2.6.4 Other Diseases
2.6.4.1 Diabetes
2.6.4.2 Inflammatory Diseases

3. KEY MARKET TRENDS
3.1 Plasma Metabolites as Biomarkers in Predicting Alzheimer?s Disease
3.2 The Age of ?Omics? Technologies and Metabolomics in Identifying New Biomarkers of Metabolic Disease Risk
3.3 Prospects for Metabolomics in Dyslipidemia
3.4 Metabolomics and the Process of Aging
3.5 Population-Based Research and Metabolomics
3.6 Breast Cancer Metabolomics and Genetics Jointly Analyzed
3.7 Metabolomics and its Role in Developing Biomarkers for Pulmonary Hypertension and Other Cardiovascular Diseases
3.8 Application of Metabolomics in Glioblastoma
3.9 Assessment of Toxic Nephropathy and Acute Kidney Injury (AKI) in Neonatology Using Metabolomics
3.9.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
3.9.2 Kidney Injury Molecule-1 (KIM-1)
3.10 Diagnosis and Surveillance of Gastric Cancer and the Potential Role of Metabolomics
3.11 Enhanced Urinary Biomarker Panel for Bipolar Disorder from Combined Application NMR- and GC-MS-Based Metabolomics
3.12 Consequences of Sleep Deprivation on the Human Metabolome
3.13 DHA Offers Potential of Reducing Risk of Metabolic Conditions
3.14 Innovative Metabolomics Technology for Discovering Cigarette Smokers at Highest Risk for COPD
3.15 Metabolomics for Children with Autism Spectrum Disorders

4. KEY GLOBAL PLAYERS

5. KEY BUSINESS TRENDS
Thermo Fisher Scientific Inc Announces New Immunoassay for Identification of Hydrocodone
Agilent Technologies and University of Toronto in Collaboration
BIOCRATES Life Sciences AG Introduces Standardized Metabolomics-Based Bile Acids Kit
Metabolon Collaborates with Metdia Biotech for European Launch of Quantose™ Prediabetes Tests
Human Metabolome Technologies and MYOS Corporation Enter Into Research Agreement
Phenomenome Discoveries Inc (PDI) in Collaboration with Bio Medical Laboratories
Waters Introduces Progenesis QI Version 2.0 for Small Molecule Data Analysis
IROA Technologies and University of Florida in a Partnership
Chenomx Launches NMR Suite Version 8.0
Bio-Rad Launches Bio-Plex Pro™ RBM Human Metabolic and Hormone Assays
Bio-Rad Introduces Vitamin D Kit for BioPlex 2200 system
Bruker Corporation Installs the World?s Highest Field 21 Tesla Magnet for FT-ICR Mass Spectrometry
Metabolon Collaborates with PATIA Biopharma
AB Sciex Launches MasterView™ Food Testing Software
Agilent Technologies and Bruker in an Agreement
Bruker Launches a Slew of Solutions
Agilent Technologies and Seoul National University in Collaboration
Metabolon and GSK in a Partnership
Shimadzu Introduces New Gas Chromatograph Mass Spectrometer
Metabolon Introduces Fourth Generation DiscoveryHD4™ Metabolomics Platform
Metabolon Introduces MetaboLync™
AB SCIEX?s Releases Newborn Screening Solution
Bruker Launches GC-APCI II GC-MS Interface with Automatic MS Calibration
BIOCRATES Launches AbsoluteIDQ® p180 for Alzheimer?s disease
Metabolon Enters Into Collaboration with Human Longevity, Inc.
AB Sciex Develops Therapeutic Biologics with Novel CESI-MS
Metabolon in Multiple Collaborations
Genedata Launches Expressionist® 8.0 for Mass Spectrometry
Agilent Technologies Launches New ProPulse NMR Platform
Human Metabolome Technologies Granted Patent from Japanese Patent Office
Global Genomics Group (G3) Partners with Metabolon
LipoScience Collaborates with Scripps Health
AB SCIEX Expands Singapore Operations
AB SCIEX Opens New Facility in the Middle East
Agilent Technologies Partners with Daegu Gyeongbuk Institute of Science and Technology
Chenomx Releases New Version of NMR Suite
Bruker Releases maXis™ HD Ultra-High Resolution QTOF
Agilent Technologies Splits Business Operations
Bruker Develops Cost-Effective Approach for Screening Inborn Errors of Metabolism using NMR
Shimadzu Launches LabSolutions CS Chromatography Data System
Metabolon and DHMRI in Collaboration
Shimadzu Launches the LCMS-8050 High-Sensitivity, Ultra-Fast Triple Quadrupole LC-MS/MS
AB SCIEX, Genedata and LECO in Partnership
LipoScience and Arup Clinical Laboratories Enter Into an Agreement
Thermo Fisher Introduces LC-MS Software for High Performance Mass Spectrometry
Metabolon?s Quantose™ Prediabetes Test Offers Diabetes Outcome Studies
Shimadzu Launches new LC/MS/MS Method Package for Primary Metabolites
AB SCIEX, Genedata and LECO in Partnership
Waters Expands its Product Line by Launching SYNAPT G2-Si Mass Spectrometer
Bruker Collaborates with SCiLS GmbH for Using SCiLS Lab Software in MALDI Imaging
Agilent Technologies and Shimadzu in an Agreement
LipoScience Commences Clinical Development of NMR-Based Cardiovascular Diagnostic Test
Metabolon Launches TrueVision™ Metabolomics Offering and Online Client Tools
Agilent Launches Improved NMR Data-Acquisition Software
AB SCIEX and LECO in a Partnership
LipoScience in a Research Agreement with Duke University School of Medicine
Chenomx Inc. and Spain?s Centre for Omic Sciences Enter into Partnership
Human Metabolome Technologies? US Operations Expanded
Genedata and LECO in a Partnership
Bruker Launches eXtreme Resolution (XR™) Fourier Transform Mass Spectrometer (FTMS)
Waters and Non Linear Dynamics in a Joint Development Agreement
Lipomics Technologies Acquired by Metabolon
Metabolon Technology Enters Into Germany with Validation of Helmholtz Zentrum Muenchen Laboratory
PDI and Polymedco CDP Enter Into Licensing Agreement
Agilent Technologies Acquires Dako
BIOCRATES? Launches AbsoluteIDQ® p180 und p150 for Waters Xevo® TQ MS Editions
AB SCIEX Introduces New TripleTOF® 5600 System
Metabolon and Takeda in a Research Alliance
Expansion of AB SCIEX?s Brazilian Commercial Operations
Metabolon?s Analytical Methods Granted Patent
BIOCRATES Expands its European Distribution Network
LipoScience Applies for FDA 510(K) for Vantera® Clinical Analyzer
Stemina Biomarker Discovery and Integrated Laboratory Systems (ILS) in Collaboration
Shimadzu Enters Into a Research Agreement with Shimane University
Shimadzu and the University of Tokyo in Collaboration
Metabolomic Discoveries GmbH and Durakult Enter Into a Research Partnership
Metabolon Awarded Two Patents by United States Patent and Trademark Office
Thermo Fisher Scientific Launches Workflow for Metabolomics Research
Metabolon Granted Patent for Metabolomics Methods in Drug Discovery
Metabolon?s Biochemical Analysis Platform Granted Patent
Stemina Biomarker Discovery Enters Into Europe through a Distribution Agreement with CIT
Shimadzu and CiRA Announce a Joint Research Agreement
Stemina Biomarker Discoveryand Pioneer Hi-Bred Announce a Joint Research Agreement
Stemina Biomarker Discovery, Inc. and Agilent Technologies in an Agreement
SpectralWorks Limited Enters China through a Distributor Agreement with Labcare Scientific
Eksigent Liquid Chromatography Operations Taken Over by AB SCIEX

6. GLOBAL MARKET OVERVIEW

6.1 Market Overview by Metabolomics Analytical Technique
6.1.1 Metabolomic Analytical Technique Market Overview by Separation Technique
6.1.1.1 Metabolomics Separation Techniques Overview by Region
6.1.1.1.1 Capillary Electrophoresis
6.1.1.1.2 Gas Chromatography
6.1.1.1.3 High Performance Liquid Chromatography (HPLC)
6.1.1.1.4 Ultra Performance Liquid Chromatography (UPLC)
6.1.2 Metabolomic Analytical Technique Market Overview by Detection Technique
6.1.2.1 Metabolomics Detection Techniques Overview by Region
6.1.2.1.1 Mass Spectrometry
6.1.2.1.2 Nuclear Magnetic Resonance Spectroscopy
6.1.2.1.3 Surface-Based Mass Analysis

6.2 Market Overview by Metabolomics Application Area
6.2.1 Metabolomics Application Area Overview by Region
6.2.1.1 Biomarker Discovery
6.2.1.2 Drug Discovery
6.2.1.3 Nutrigenomics
6.2.1.4 Toxicology Testing
6.2.1.5 Other Applications

6.3 Market Overview by Metabolomics Therapeutic Area
6.3.1 Metabolomics Therapeutic Area Overview by Region
6.3.1.1 Cardiology
6.3.1.2 Neurology
6.3.1.3 Oncology
6.3.1.4 Other Diseases

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. NORTH AMERICA
1.1 Market Overview by Geographic Region
1.2 Market Overview by Metabolomics Analytical Technique
1.2.1 Metabolomic Analytical Technique Market Overview by Separation Technique
1.2.1.1 Metabolomics Separation Techniques Overview by NA Region
1.2.1.1.1 Capillary Electrophoresis
1.2.1.1.2 Gas Chromatography
1.2.1.1.3 High Performance Liquid Chromatography (HPLC)
1.2.1.1.4 Ultra Performance Liquid Chromatography (UPLC)
1.2.2 Metabolomic Analytical Technique Market Overview by Detection Technique
1.2.2.1 Metabolomics Detection Techniques Overview by NA Region
1.2.2.1.1 Mass Spectrometry
1.2.2.1.2 Nuclear Magnetic Resonance Spectroscopy
1.2.2.1.3 Surface-Based Mass Analysis
1.3 Market Overview by Metabolomics Application Area
1.3.1 Metabolomics Application Area Overview by NA Region
1.3.1.1 Biomarker Discovery
1.3.1.2 Drug Discovery
1.3.1.3 Nutrigenomics
1.3.1.4 Toxicology Testing
1.3.1.5 Other Applications
1.4 Market Overview by Metabolomics Therapeutic Area
1.4.1 Metabolomics Therapeutic Area by NA Region
1.4.1.1 Cardiology
1.4.1.2 Neurology
1.4.1.3 Oncology
1.4.1.4 Other Diseases
1.5 Major Market Players
Agilent Technologies
Bio-Rad Laboratories, Inc.
Bruker Corporation
Chenomx Inc. (Canada)
Danaher Corporation
AB SCIEX
Eksigent
IROA Technologies
LECO Corporation
Liposcience, Inc.
Metabolomic Technologies Inc. (Canada)
Metabolomx
Metabolon, Inc.
Microsolv Technology Corporation
Phenomenome Discoveries Inc. (Canada)
Sigma-Aldrich Co. LLC.
Stemina Biomarker Discovery, Inc.
Thermo Fisher Scientific Inc
Waters Corporation
Nonlinear Dynamics Limited

1.6 North America Metabolomics Market Overview by Country
1.6.1 The United States
1.6.1.1 Market Overview by Metabolomics Analytical Technique
1.6.1.1.1 Analytical Technique Market Overview by Separation Technique
1.6.1.1.2 Analytical Technique Market Overview by Detection Technique
1.6.1.2 Market Overview by Metabolomics Application Area
1.6.1.3 Market Overview by Metabolomics Therapeutic Area

1.6.2 Canada
1.6.2.1 Market Overview by Metabolomics Analytical Technique
1.6.2.1.1 Analytical Technique Market Overview by Separation Technique
1.6.2.1.2 Analytical Technique Market Overview by Detection Technique
1.6.2.2 Market Overview by Metabolomics Application Area
1.6.2.3 Market Overview by Metabolomics Therapeutic Area

2. EUROPE
2.1 Market Overview by Geographic Region
2.2 Market Overview by Metabolomics Analytical Technique
2.2.1 Metabolomic Analytical Technique Market Overview by Separation Technique
2.2.1.1 Metabolomics Separation Techniques Overview by European Region
2.2.1.1.1 Capillary Electrophoresis
2.2.1.1.2 Gas Chromatography
2.2.1.1.3 High Performance Liquid Chromatography (HPLC)
2.2.1.1.4 Ultra Performance Liquid Chromatography (UPLC)
2.2.2 Metabolomic Analytical Technique Market Overview by Detection Technique
2.2.2.1 Metabolomics Detection Techniques Overview by European Region
2.2.2.1.1 Mass Spectrometry
2.2.2.1.2 Nuclear Magnetic Resonance Spectroscopy
2.2.2.1.3 Surface-Based Mass Analysis
2.3 Market Overview by Metabolomics Application Area
2.3.1 Metabolomics Application Area Overview by European Region
2.3.1.1 Biomarker Discovery
2.3.1.2 Drug Discovery
2.3.1.3 Nutrigenomics
2.3.1.4 Toxicology Testing
2.3.1.5 Other Applications
2.4 Market Overview by Metabolomics Therapeutic Area
2.4.1 Metabolomics Therapeutic Area by European Region
2.4.1.1 Cardiology
2.4.1.2 Neurology
2.4.1.3 Oncology
2.4.1.4 Other Diseases
2.5 Major Market Players
Biocrates Life Sciences AG (Austria)
BASF SE (Germany)
Metanomics GmbH
Metanomics Health GmbH
Dataapex (Czech Republic)
Genedata AG (Germany)
Gerstel Gmbh & Co. Kg (Germany)
Metabolomic Discoveries GmbH (Germany)
Spectralworks Ltd (United Kingdom)

2.6 European Metabolomics Market Overview by Country
2.6.1 France
2.6.1.1 Market Overview by Metabolomics Analytical Technique
2.6.1.1.1 Analytical Technique Market Overview by Separation Technique
2.6.1.1.2 Analytical Technique Market Overview by Detection Technique
2.6.1.2 Market Overview by Metabolomics Application Area
2.6.1.3 Market Overview by Metabolomics Therapeutic Area

2.6.2 Germany
2.6.2.1 Market Overview by Metabolomics Analytical Technique
2.6.2.1.1 Analytical Technique Market Overview by Separation Technique
2.6.2.1.2 Analytical Technique Market Overview by Detection Technique
2.6.2.2 Market Overview by Metabolomics Application Area
2.6.2.3 Market Overview by Metabolomics Therapeutic Area

2.6.3 Italy
2.6.3.1 Market Overview by Metabolomics Analytical Technique
2.6.3.1.1 Analytical Technique Market Overview by Separation Technique
2.6.3.1.2 Analytical Technique Market Overview by Detection Technique
2.6.3.2 Market Overview by Metabolomics Application Area
2.6.3.3 Market Overview by Metabolomics Therapeutic Area

2.6.4 The United Kingdom
2.6.4.1 Market Overview by Metabolomics Analytical Technique
2.6.4.1.1 Analytical Technique Market Overview by Separation Technique
2.6.4.1.2 Analytical Technique Market Overview by Detection Technique
2.6.4.2 Market Overview by Metabolomics Application Area
2.6.4.3 Market Overview by Metabolomics Therapeutic Area

2.6.5 Rest of Europe
2.6.5.1 Market Overview by Metabolomics Analytical Technique
2.6.5.1.1 Analytical Technique Market Overview by Separation Technique
2.6.5.1.2 Analytical Technique Market Overview by Detection Technique
2.6.5.2 Market Overview by Metabolomics Application Area
2.6.5.3 Market Overview by Metabolomics Therapeutic Area

3. ASIA-PACIFIC
3.1 Market Overview by Geographic Region
3.2 Market Overview by Metabolomics Analytical Technique
3.2.1 Metabolomic Analytical Technique Market Overview by Separation Technique
3.2.1.1 Metabolomics Separation Techniques Overview by Asia-Pacific Region
3.2.1.1.1 Capillary Electrophoresis
3.2.1.1.2 Gas Chromatography
3.2.1.1.3 High Performance Liquid Chromatography (HPLC)
3.2.1.1.4 Ultra Performance Liquid Chromatography (UPLC)
3.2.2 Metabolomic Analytical Technique Market Overview by Detection Technique
3.2.2.1 Metabolomics Detection Techniques Overview by Asia-Pacific Region
3.2.2.1.1 Mass Spectrometry
3.2.2.1.2 Nuclear Magnetic Resonance Spectroscopy
3.2.2.1.3 Surface-Based Mass Analysis
3.3 Market Overview by Metabolomics Application Area
3.3.1 Metabolomics Application Area Overview by Asia-Pacific Region
3.3.1.1 Biomarker Discovery
3.3.1.2 Drug Discovery
3.3.1.3 Nutrigenomics
3.3.1.4 Toxicology Testing
3.3.1.5 Other Applications
3.4 Market Overview by Metabolomics Therapeutic Area
3.4.1 Metabolomics Therapeutic Area by Asia-Pacific Region
3.4.1.1 Cardiology
3.4.1.2 Neurology
3.4.1.3 Oncology
3.4.1.4 Other Diseases
3.5 Major Market Players
Hitachi High-Technologies Corporation (Japan)
Human Metabolome Technologies, Inc. (Japan)
JEOL Ltd. (Japan)
Shimadzu Corporation (Japan)

3.6 Asia-Pacific Metabolomics Market Overview by Country
3.6.1 China
3.6.1.1 Market Overview by Metabolomics Analytical Technique
3.6.1.1.1 Analytical Technique Market Overview by Separation Technique
3.6.1.1.2 Analytical Technique Market Overview by Detection Technique
3.6.1.2 Market Overview by Metabolomics Application Area
3.6.1.3 Market Overview by Metabolomics Therapeutic Area

3.6.2 India
3.6.2.1 Market Overview by Metabolomics Analytical Technique
3.6.2.1.1 Analytical Technique Market Overview by Separation Technique
3.6.2.1.2 Analytical Technique Market Overview by Detection Technique
3.6.2.2 Market Overview by Metabolomics Application Area
3.6.2.3 Market Overview by Metabolomics Therapeutic Area

3.6.3 Japan
3.6.3.1 Market Overview by Metabolomics Analytical Technique
3.6.3.1.1 Analytical Technique Market Overview by Separation Technique
3.6.3.1.2 Analytical Technique Market Overview by Detection Technique
3.6.3.2 Market Overview by Metabolomics Application Area
3.6.3.3 Market Overview by Metabolomics Therapeutic Area

3.6.4 Rest of Asia-Pacific
3.6.4.1 Market Overview by Metabolomics Analytical Technique
3.6.4.1.1 Analytical Technique Market Overview by Separation Technique
3.6.4.1.2 Analytical Technique Market Overview by Detection Technique
3.6.4.2 Market Overview by Metabolomics Application Area
3.6.4.3 Market Overview by Metabolomics Therapeutic Area

4. REST OF WORLD
4.1 Market Overview by Metabolomics Analytical Technique
4.1.1 Metabolomic Analytical Technique Market Overview by Separation Technique
4.1.2 Metabolomic Analytical Technique Market Overview by Detection Technique
4.2 Market Overview by Metabolomics Application Area
4.3 Market Overview by Metabolomics Therapeutic Area

PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
1.1 Canada
1.2 United States

2. EUROPE
2.1 Austria
2.2 Belgium
2.3 Czech Republic
2.4 France
2.5 Germany
2.6 Ireland
2.7 Italy
2.8 Sweden
2.9 Switzerland
2.10 The Netherlands
2.11 United Kingdom

3. ASIA-PACIFIC
3.1 Japan

PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Trending of Metabolomic Separation Techniques Market (2014 & 2020) in USD Million
Chart 2: Trending of Metabolomic Detection Techniques Market (2014 & 2020) in USD Million
Chart 3: Trending of Market for Applications of Metabolomics (2014 & 2020) in USD Million
Chart 4: Trending of Market for Therapeutic Areas of Metabolomics (2014 & 2020) in USD Million
Chart 5: Global Metabolomics Market Analysis (2010-2020) in USD Million
Chart 6: Global Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 7: Glance at 2010, 2015 and 2020 Global Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 8: Global Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 9: Glance at 2010, 2015 and 2020 Global Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 10: Global Market for Capillary Electrophoresis Separation Technique in Metabolomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 11: Glance at 2010, 2015 and 2020 Global Market for Capillary Electrophoresis Separation Technique in Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 12: Global Market for Gas Chromatography Separation Technique in Metabolomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 13: Glance at 2010, 2015 and 2020 Global Market for Gas Chromatography Separation Technique in Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 14: Global Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 15: Glance at 2010, 2015 and 2020 Global Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 16: Global Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 17: Glance at 2010, 2015 and 2020 Global Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 18: Global Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 19: Glance at 2010, 2015 and 2020 Global Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 20: Global Market for Mass Spectrometry Detection Technique in Metabolomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 21: Glance at 2010, 2015 and 2020 Global Market for Mass Spectrometry Detection Technique in Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 22: Global Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 23: Glance at 2010, 2015 and 2020 Global Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 24: Global Market for Surface-Based Mass Analysis Detection Technique in Metabolomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 25: Glance at 2010, 2015 and 2020 Global Market for Surface-Based Mass Analysis Detection Technique in Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 26: Global Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 27: Glance at 2010, 2015 and 2020 Global Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 28: Global Market for Metabolomics in Biomarker Discovery (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 29: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Biomarker Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 30: Global Market for Metabolomics in Drug Discovery (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 31: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Drug Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 32: Global Market for Metabolomics in Nutrigenomics (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 33: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Nutrigenomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 34: Global Market for Metabolomics in Toxicology Testing (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 35: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Toxicology Testing Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 36: Global Market for Metabolomics in Other Applications (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 37: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Other Applications Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 38: Global Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 39: Glance at 2010, 2015 and 2020 Global Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases
Chart 40: Global Market for Metabolomics in Cardiology (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 41: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Cardiology Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 42: Global Market for Metabolomics in Neurology (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 43: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Neurology Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 44: Global Market for Metabolomics in Oncology (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 45: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Oncology Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 46: Global Market for Metabolomics in Other Diseases (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 47: Glance at 2010, 2015 and 2020 Global Market for Metabolomics in Other Diseases Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE
Chart 48: The Projection of Largest Regions in terms of Market Growth (2014-2020) for Metabolomics by Geography - Asia-Pacific, Europe and North America
Chart 49: Global Metabolomics Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 50: Glance at 2010, 2015 and 2020 Global Metabolomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA
Chart 51: North American Metabolomics Market Analysis (2010-2020) in USD Million
Chart 52: North American Metabolomics Market Analysis (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 53: Glance at 2010, 2015 and 2020 North American Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 54: North American Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 55: Glance at 2010, 2015 and 2020 North American Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 56: North American Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 57: Glance at 2010, 2015 and 2020 North American Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 58: North American Market for Capillary Electrophoresis Separation Technique in Metabolomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 59: Glance at 2010, 2015 and 2020 North American Market for Capillary Electrophoresis Separation Technique in Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 60: North American Market for Gas Chromatography Separation Technique in Metabolomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 61: Glance at 2010, 2015 and 2020 North American Market for Gas Chromatography Separation Technique in Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 62: North American Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 63: Glance at 2010, 2015 and 2020 North American Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 64: North American Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 65: Glance at 2010, 2015 and 2020 North American Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 66: North American Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 67: Glance at 2010, 2015 and 2020 North American Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 68: North American Market for Mass Spectrometry Detection Technique in Metabolomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 69: Glance at 2010, 2015 and 2020 North American Market for Mass Spectrometry Detection Technique in Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 70: North American Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 71: Glance at 2010, 2015 and 2020 North American Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 72: North American Market for Surface-Based Mass Analysis Detection Technique in Metabolomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 73: Glance at 2010, 2015 and 2020 North American Market for Surface-Based Mass Analysis Detection Technique in Metabolomics Market Share (%) by Geographic Region - United States and Canada
Chart 74: North American Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 75: Glance at 2010, 2015 and 2020 North American Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 76: North American Market for Metabolomics in Biomarker Discovery (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 77: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Biomarker Discovery Market Share (%) by Geographic Region - United States and Canada
Chart 78: North American Market for Metabolomics in Drug Discovery (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 79: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Drug Discovery Market Share (%) by Geographic Region - United States and Canada
Chart 80: North American Market for Metabolomics in Nutrigenomics (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 81: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Nutrigenomics Market Share (%) by Geographic Region - United States and Canada
Chart 82: North American Market for Metabolomics in Toxicology Testing (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 83: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Toxicology Testing Market Share (%) by Geographic Region - United States and Canada
Chart 84: North American Market for Metabolomics in Other Applications (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 85: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Other Applications Market Share (%) by Geographic Region - United States and Canada
Chart 86: North American Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 87: Glance at 2010, 2015 and 2020 North American Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases
Chart 88: North American Market for Metabolomics in Cardiology (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 89: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Cardiology Market Share (%) by Geographic Region - United States and Canada
Chart 90: North American Market for Metabolomics in Neurology (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 91: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Neurology Market Share (%) by Geographic Region - United States and Canada
Chart 92: North American Market for Metabolomics in Oncology (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 93: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Oncology Market Share (%) by Geographic Region - United States and Canada
Chart 94: North American Market for Metabolomics in Other Diseases (2010-2020) by Geographic Region - United States and Canada in USD Million
Chart 95: Glance at 2010, 2015 and 2020 North American Market for Metabolomics in Other Diseases Market Share (%) by Geographic Region - United States and Canada

The United States
Chart 96: United States Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 97: Glance at 2010, 2015 and 2020 United States Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 98: United States Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 99: Glance at 2010, 2015 and 2020 United States Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 100: United States Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 101: Glance at 2010, 2015 and 2020 United States Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 102: United States Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 103: Glance at 2010, 2015 and 2020 United States Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 104: United States Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 105: Glance at 2010, 2015 and 2020 United States Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

Canada
Chart 106: Canadian Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 107: Glance at 2010, 2015 and 2020 Canadian Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 108: Canadian Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 109: Glance at 2010, 2015 and 2020 Canadian Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 110: Canadian Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 111: Glance at 2010, 2015 and 2020 Canadian Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 112: Canadian Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 113: Glance at 2010, 2015 and 2020 Canadian Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 114: Canadian Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 115: Glance at 2010, 2015 and 2020 Canadian Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

EUROPE
Chart 116: European Metabolomics Market Analysis (2010-2020) in USD Million
Chart 117: European Metabolomics Market Analysis (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 118: Glance at 2010, 2015 and 2020 European Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 119: European Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 120: Glance at 2010, 2015 and 2020 European Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 121: European Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 122: Glance at 2010, 2015 and 2020 European Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 123: European Market for Capillary Electrophoresis Separation Technique in Metabolomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 124: Glance at 2010, 2015 and 2020 European Market for Capillary Electrophoresis Separation Technique in Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 125: European Market for Gas Chromatography Separation Technique in Metabolomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 126: Glance at 2010, 2015 and 2020 European Market for Gas Chromatography Separation Technique in Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 127: European Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 128: Glance at 2010, 2015 and 2020 European Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 129: European Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 130: Glance at 2010, 2015 and 2020 European Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 131: European Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 132: Glance at 2010, 2015 and 2020 European Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 133: European Market for Mass Spectrometry Detection Technique in Metabolomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 134: Glance at 2010, 2015 and 2020 European Market for Mass Spectrometry Detection Technique in Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 135: European Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 136: Glance at 2010, 2015 and 2020 European Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 137: European Market for Surface-Based Mass Analysis Detection Technique in Metabolomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 138: Glance at 2010, 2015 and 2020 European Market for Surface-Based Mass Analysis Detection Technique in Metabolomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 139: European Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 140: Glance at 2010, 2015 and 2020 European Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 141: European Market for Metabolomics in Biomarker Discovery (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 142: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Biomarker Discovery Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 143: European Market for Metabolomics in Drug Discovery (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 144: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Drug Discovery Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 145: European Market for Metabolomics in Nutrigenomics (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 146: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Nutrigenomics Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 147: European Market for Metabolomics in Toxicology Testing (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 148: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Toxicology Testing Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 149: European Market for Metabolomics in Other Applications (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 150: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Other Applications Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 151: European Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 152: Glance at 2010, 2015 and 2020 European Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases
Chart 153: European Market for Metabolomics in Cardiology (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 154: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Cardiology Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 155: European Market for Metabolomics in Neurology (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 156: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Neurology Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 157: European Market for Metabolomics in Oncology (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 158: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Oncology Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
Chart 159: European Market for Metabolomics in Other Diseases (2010-2020) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 160: Glance at 2010, 2015 and 2020 European Market for Metabolomics in Other Diseases Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe

France
Chart 161: French Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 162: Glance at 2010, 2015 and 2020 French Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 163: French Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 164: Glance at 2010, 2015 and 2020 French Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 165: French Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 166: Glance at 2010, 2015 and 2020 French Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 167: French Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 168: Glance at 2010, 2015 and 2020 French Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 169: French Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 170: Glance at 2010, 2015 and 2020 French Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

Germany
Chart 171: German Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 172: Glance at 2010, 2015 and 2020 German Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 173: German Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 174: Glance at 2010, 2015 and 2020 German Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 175: German Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 176: Glance at 2010, 2015 and 2020 German Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 177: German Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 178: Glance at 2010, 2015 and 2020 German Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 179: German Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 180: Glance at 2010, 2015 and 2020 German Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

Italy
Chart 181: Italian Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 182: Glance at 2010, 2015 and 2020 Italian Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 183: Italian Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 184: Glance at 2010, 2015 and 2020 Italian Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 185: Italian Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 186: Glance at 2010, 2015 and 2020 Italian Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 187: Italian Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 188: Glance at 2010, 2015 and 2020 Italian Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 189: Italian Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 190: Glance at 2010, 2015 and 2020 Italian Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

The United Kingdom
Chart 191: United Kingdom Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 192: Glance at 2010, 2015 and 2020 United Kingdom Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 193: United Kingdom Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 194: Glance at 2010, 2015 and 2020 United Kingdom Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 195: United Kingdom Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 196: Glance at 2010, 2015 and 2020 United Kingdom Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 197: United Kingdom Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 198: Glance at 2010, 2015 and 2020 United Kingdom Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 199: United Kingdom Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 200: Glance at 2010, 2015 and 2020 United Kingdom Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

Rest of Europe
Chart 201: Rest of Europe Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 202: Glance at 2010, 2015 and 2020 Rest of Europe Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 203: Rest of Europe Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 204: Glance at 2010, 2015 and 2020 Rest of Europe Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 205: Rest of Europe Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 206: Glance at 2010, 2015 and 2020 Rest of Europe Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 207: Rest of Europe Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 208: Glance at 2010, 2015 and 2020 Rest of Europe Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 209: Rest of Europe Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 210: Glance at 2010, 2015 and 2020 Rest of Europe Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

ASIA-PACIFIC
Chart 211: Asia-Pacific Metabolomics Market Analysis (2010-2020) in USD Million
Chart 212: Asia-Pacific Metabolomics Market Analysis (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 213: Glance at 2010, 2015 and 2020 Asia-Pacific Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 214: Asia-Pacific Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 215: Glance at 2010, 2015 and 2020 Asia-Pacific Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 216: Asia-Pacific Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 217: Glance at 2010, 2015 and 2020 Asia-Pacific Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 218: Asia-Pacific Market for Capillary Electrophoresis Separation Technique in Metabolomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 219: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Capillary Electrophoresis Separation Technique in Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 220: Asia-Pacific Market for Gas Chromatography Separation Technique in Metabolomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 221: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Gas Chromatography Separation Technique in Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 222: Asia-Pacific Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 223: Glance at 2010, 2015 and 2020 Asia-Pacific Market for High Performance Liquid Chromatography (HPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 224: Asia-Pacific Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 225: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Ultra Performance Liquid Chromatography (UPLC) Separation Technique in Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 226: Asia-Pacific Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 227: Glance at 2010, 2015 and 2020 Asia-Pacific Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 228: Asia-Pacific Market for Mass Spectrometry Detection Technique in Metabolomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 229: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Mass Spectrometry Detection Technique in Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 230: Asia-Pacific Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 231: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Nuclear Magnetic Resonance Spectroscopy Detection Technique in Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 232: Asia-Pacific Market for Surface-Based Mass Analysis Detection Technique in Metabolomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 233: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Surface-Based Mass Analysis Detection Technique in Metabolomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 234: Asia-Pacific Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 235: Glance at 2010, 2015 and 2020 Asia-Pacific Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 236: Asia-Pacific Market for Metabolomics in Biomarker Discovery (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 237: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Biomarker Discovery Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 238: Asia-Pacific Market for Metabolomics in Drug Discovery (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 239: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Drug Discovery Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 240: Asia-Pacific Market for Metabolomics in Nutrigenomics (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 241: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Nutrigenomics Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 242: Asia-Pacific Market for Metabolomics in Toxicology Testing (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 243: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Toxicology Testing Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 244: Asia-Pacific Market for Metabolomics in Other Applications (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 245: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Other Applications Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 246: Asia-Pacific Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 247: Glance at 2010, 2015 and 2020 Asia-Pacific Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases
Chart 248: Asia-Pacific Market for Metabolomics in Cardiology (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 249: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Cardiology Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 250: Asia-Pacific Market for Metabolomics in Neurology (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 251: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Neurology Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 252: Asia-Pacific Market for Metabolomics in Oncology (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 253: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Oncology Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific
Chart 254: Asia-Pacific Market for Metabolomics in Other Diseases (2010-2020) by Geographic Region - China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 255: Glance at 2010, 2015 and 2020 Asia-Pacific Market for Metabolomics in Other Diseases Market Share (%) by Geographic Region - China, India, Japan and Rest of Asia-Pacific

China
Chart 256: Chinese Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 257: Glance at 2010, 2015 and 2020 Chinese Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 258: Chinese Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 259: Glance at 2010, 2015 and 2020 Chinese Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 260: Chinese Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 261: Glance at 2010, 2015 and 2020 Chinese Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 262: Chinese Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 263: Glance at 2010, 2015 and 2020 Chinese Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 264: Chinese Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 265: Glance at 2010, 2015 and 2020 Chinese Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

India
Chart 266: Indian Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 267: Glance at 2010, 2015 and 2020 Indian Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 268: Indian Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 269: Glance at 2010, 2015 and 2020 Indian Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 270: Indian Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 271: Glance at 2010, 2015 and 2020 Indian Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 272: Indian Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 273: Glance at 2010, 2015 and 2020 Indian Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 274: Indian Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 275: Glance at 2010, 2015 and 2020 Indian Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

Japan
Chart 276: Japanese Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 277: Glance at 2010, 2015 and 2020 Japanese Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 278: Japanese Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 279: Glance at 2010, 2015 and 2020 Japanese Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 280: Japanese Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 281: Glance at 2010, 2015 and 2020 Japanese Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 282: Japanese Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 283: Glance at 2010, 2015 and 2020 Japanese Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 284: Japanese Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 285: Glance at 2010, 2015 and 2020 Japanese Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

Rest of Asia-Pacific
Chart 286: Rest of Asia-Pacific Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 287: Glance at 2010, 2015 and 2020 Rest of Asia-Pacific Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 288: Rest of Asia-Pacific Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 289: Glance at 2010, 2015 and 2020 Rest of Asia-Pacific Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 290: Rest of Asia-Pacific Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 291: Glance at 2010, 2015 and 2020 Rest of Asia-Pacific Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 292: Rest of Asia-Pacific Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 293: Glance at 2010, 2015 and 2020 Rest of Asia-Pacific Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 294: Rest of Asia-Pacific Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 295: Glance at 2010, 2015 and 2020 Rest of Asia-Pacific Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

REST OF WORLD
Chart 296: Rest of World Metabolomics Market Analysis (2010-2020) in USD Million
Chart 297: Rest of World Metabolomics Market Analysis (2010-2020) by Analytical Technique - Separation Techniques and Detection Techniques in USD Million
Chart 298: Glance at 2010, 2015 and 2020 Rest of World Metabolomics Market Share (%) by Analytical Technique - Separation Techniques and Detection Techniques
Chart 299: Rest of World Metabolomics Market Analysis (2010-2020) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) in USD Million
Chart 300: Glance at 2010, 2015 and 2020 Rest of World Metabolomics Market Share (%) by Separation Technique - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC)
Chart 301: Rest of World Metabolomics Market Analysis (2010-2020) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis in USD Million
Chart 302: Glance at 2010, 2015 and 2020 Rest of World Metabolomics Market Share (%) by Detection Technique - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis
Chart 303: Rest of World Metabolomics Market Analysis (2010-2020) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications in USD Million
Chart 304: Glance at 2010, 2015 and 2020 Rest of World Metabolomics Market Share (%) by Application Area - Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications
Chart 305: Rest of World Metabolomics Market Analysis (2010-2020) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases in USD Million
Chart 306: Glance at 2010, 2015 and 2020 Rest of World Metabolomics Market Share (%) by Therapeutic Area - Cardiology, Neurology, Oncology and Other Diseases

Figures & Tables

Fig 1: Capillary Electrophoresis
Fig 2: Gas Chromatography
Fig 3: High Performance Liquid Chromatography (HPLC)
Fig 4: HPLC and UPLC Comparison
Fig 5: Mass Spectrometry
Fig 6: Nuclear Magnetic Resonance (NMR) Spectroscopy

Table 1: A Comparative Assessment of the Strengths and Weaknesses of Mass Spectrometry (MS) and Nuclear Magnetic Resonance Spectrometry in Metabolic Profiling
Table 2: Advantages and Disadvantages of Metabolomics in Toxicology
Table 3: Dietary Diomarkers Identified through Approaches based on Metabolomics
Table 4: Various Metabolic Signatures in Neurological Disorders
Table 5: Major Metabolites and their Association with Inflammatory Diseases
Table 6: Identified Biomarkers for Hyperlipidemia in Animal Model Studies

Agilent Technologies
BASF SE
Biocrates Life Sciences AG
Bio-Rad Laboratories, Inc.
Bruker Corporation
Danaher Corporation
Genedata AG
GERSTEL GmbH & Co. KG
Human Metabolome Technologies, Inc.
LECO Corporation
Metabolomic Discoveries GmbH
Metabolomic Technologies Inc.
Metabolomx
Metabolon, Inc.
Phenomenome Discoveries Inc.
Shimadzu Corporation
Sigma-Aldrich Co. LLC.
Stemina Biomarker Discovery, Inc.
Thermo Fisher Scientific Inc
Waters Corporation

PLEASE SELECT LICENSE TYPE

Have a question
About this report?

EMAIL US

Subscribe to Newsletter
for all latest updates

SUBSCRIBE

RELATED REPORTS

bt026-polymerase-chain-reaction-pcr-a-global-market-overview

Polymerase Chain Reaction (PCR) – A Global Market Overview
Report Code: BT026 | Pages: 344 | Price: $4860

Published
Oct 2017

bt012-biosensors-a-global-market-overview

Biosensors – A Global Market Overview
Report Code: BT012 | Pages: 280 | Price: $4050

Published
Oct 2017

BioMEMS-Devices-A-Global-Market-Overview

BioMEMS Devices – A Global Market Overview
Report Code: BT016 | Pages: 178 | Price: $4050

Published
Jan 2016

tissue-engineering-technologies-and-therapeutic-areas-a-global-market-overview

Published
Sep 2015

BT015-Biometrics-A-Global-Market-Overview

Biometrics – A Global Market Overview
Report Code: BT015 | Pages: 410 | Price: $4500

Published
Jan 2015